Search results for CD204 Antibody

CD204 Antibody, MedChemexpress, HY-P80758

CD204 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to CD204.

CD204 Antibody (YA3879), MedChemexpress, HY-P84182

CD204 Antibody (YA3879) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CD204.

Anti-CD204 antibody, Abcam, AB123946

Anti-CD204 antibody, Abcam, AB217843

Anti-CD204 antibody [EPR7536], Abcam, AB151707

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD204 antibody [RM2033], Abcam, AB315834

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

CD204 Antibody (YA3879)(PBS only), MedChemexpress, HY-P84182A

CD204 Antibody (YA3879) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CD204.

FITC Anti-CD204 antibody [004], Abcam, AB275706

Anti-CD204 antibody [EPR24403-17], Abcam, AB271070

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD204 antibody [EPR28270-88], Abcam, AB314227

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .